155 related articles for article (PubMed ID: 1420497)
1. Intraperitoneal administration of recombinant human erythropoietin.
Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
[TBL] [Abstract][Full Text] [Related]
2. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
Nasu T; Mitui H; Shinohara Y; Hayashida S; Ohtuka H
Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Pais MJ; Gaspar A; Santana A; Bruges M; Simões J
Perit Dial Int; 1993; 13 Suppl 2():S541-3. PubMed ID: 8399660
[TBL] [Abstract][Full Text] [Related]
4. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lui SF; Law CB; Ting SM; Li P; Lai KN
Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
[TBL] [Abstract][Full Text] [Related]
5. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lui SF; Leung JC; Law E; Nicholls MG
Nephron; 1991; 57(4):394-400. PubMed ID: 1828543
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of recombinant human erythropoietin administered subcutaneously to CAPD patients once weekly.
Frifelt JJ; Tvedegaard E; Bruun K; Steffensen G; Cintin C; Breddam M; Dominguez H; Jørgensen JD
Perit Dial Int; 1996; 16(6):594-8. PubMed ID: 8981527
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lui SF; Chung WW; Leung CB; Chan K; Lai KN
Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.
Bárány P; Clyne N; Hylander B; Johansson AC; Simonsen O; Larsson R; Frisenette-Fich C; Svensson B; Helmers C
Perit Dial Int; 1995; 15(1):54-60. PubMed ID: 7734561
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
Abreo K; Lubom JA; Collier L; Fleming D; Work J
Adv Perit Dial; 1994; 10():124-8. PubMed ID: 7999809
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis.
Huang TP; Lin CY
Am J Nephrol; 1995; 15(4):312-7. PubMed ID: 7573189
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
Hisano S; Kaku Y; Ueda K; Onoyama K
Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
[TBL] [Abstract][Full Text] [Related]
12. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
Cheng IK; Cy C; Chan MK; Yu L; Fang GX; Wei D
Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
[TBL] [Abstract][Full Text] [Related]
13. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis.
Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Schollmeyer P
Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous recombinant human erythropoietin in patients on CAPD.
Lye WC; Lee EJ
Adv Perit Dial; 1991; 7():285-7. PubMed ID: 1680447
[TBL] [Abstract][Full Text] [Related]
15. Efficient monthly subcutaneous administration of darbepoetin in stable CAPD patients.
Theodoridis M; Passadakis P; Kriki P; Panagoutsos S; Yannatos E; Kantartzi K; Sivridis D; Vargemezis V
Perit Dial Int; 2005; 25(6):564-9. PubMed ID: 16411523
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study.
Montini G; Zacchello G; Perfumo F; Edefonti A; Bassi S; Cantaluppi A; Sarchi C; Cazzin M; Ferrari V; Boccazzi A
J Pediatr; 1993 Feb; 122(2):297-302. PubMed ID: 8429450
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
Icardi A; Paoletti E; Molinelli G
Adv Perit Dial; 1990; 6():292-5. PubMed ID: 1982830
[TBL] [Abstract][Full Text] [Related]
20. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
Yalçinkaya F; Tümer N; Cakar N; Ozkaya N
Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]